Long-term cost-effectiveness of early and sustained clopidogrel therapy for up to 1 year in patients undergoing percutaneous coronary intervention after presenting with acute coronary syndromes without ST-segment elevation

This publication has 13 references indexed in Scilit:

• 889-3 Estimating life-years lost due to atherothrombotic events: Flexible survival functions for use in disease modeling
  Journal of the American College of Cardiology, 2004
• Cost and Cost-effectiveness of an Early Invasive vs Conservative Strategy for the Treatment of Unstable Angina and Non–ST-Segment Elevation Myocardial Infarction
  JAMA, 2002
• ACC/AHA 2002 guideline update for the management of patients with unstable angina and non–ST-segment elevation myocardial infarction—summary article
  Journal of the American College of Cardiology, 2002
• A cardiovascular life history
  Published by Oxford University Press (OUP) ,2002
• Something old, something new, something borrowed, something blue: a framework for the marriage of health econometrics and cost‐effectiveness analysis
  Health Economics, 2002
• Effects of Clopidogrel in Addition to Aspirin in Patients with Acute Coronary Syndromes without ST-Segment Elevation
  New England Journal of Medicine, 2001
• Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study
  The Lancet, 2001
• Cost-Effectiveness of Platelet Glycoprotein IIb/IIIa Inhibition With Eptifibatide in Patients With Non–ST-Elevation Acute Coronary Syndromes
  Circulation, 2000
• Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group
  Statistics in Medicine, 1998
• Costs, effects and C/E‐ratios alongside a clinical trial
  Health Economics, 1994